Education
About Us
Working with TipRanks
Follow Us
Shanghai Henlius Biotech, Inc. Class H (HK:2696)
:2696
Earnings Data
Report Date
Mar 20, 2026TBA (Not Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.62Last Year’s EPS
0.87Same Quarter Last Year
Based on 0 Analysts Ratings
Shanghai Henlius Biotech, Inc. Class H (HK:2696) Earnings, Revenues Date & History
HK:2696 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HK:2696 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 25, 2025 | HK$83.50 | HK$80.05 | -4.13% |
Mar 24, 2025 | HK$30.50 | HK$31.60 | +3.61% |
Aug 26, 2024 | HK$22.90 | HK$23.05 | +0.66% |
Mar 21, 2024 | HK$14.20 | HK$14.24 | +0.28% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Shanghai Henlius Biotech, Inc. Class H (HK:2696) report earnings?
Shanghai Henlius Biotech, Inc. Class H (HK:2696) is schdueled to report earning on Mar 20, 2026, TBA (Not Confirmed).
What is Shanghai Henlius Biotech, Inc. Class H (HK:2696) earnings time?
Shanghai Henlius Biotech, Inc. Class H (HK:2696) earnings time is at Mar 20, 2026, TBA (Not Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Shanghai Henlius Biotech, Inc. Class H stock?
The P/E ratio of Shanghai Henlius Biotech, Inc. Class H is N/A.
What is HK:2696 EPS forecast?
HK:2696 EPS forecast for the fiscal quarter 2025 (Q4) is 0.62.